Clinical characteristics of anti-Ro52/TRIM21-positive versus anti-Ro52/TRIM21-negative patients with anti-synthetase syndrome: a retrospective cohort study.
OBJECTIVES Anti-Ro52/TRIM21 antibodies have been linked to interstitial lung disease (ILD) severity in anti-synthetase syndrome (ASS), but their broader clinical relevance remains uncertain. We compared clinical, pulmonary, treatment, and outcome characteristics according to Anti-Ro52/TRIM21 status in a Swiss single-ce...